Olema Pharmaceuticals Stock Alpha and Beta Analysis
| OLMA Stock | USD 4.41 0.04 0.92% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Olema Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Olema Pharmaceuticals over a specified time horizon. Remember, high Olema Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Olema Pharmaceuticals' market risk premium analysis include:
Beta 2.59 | Alpha (0.78) | Risk 4.62 | Sharpe Ratio (0.11) | Expected Return (0.52) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Olema |
Olema Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Olema Pharmaceuticals market risk premium is the additional return an investor will receive from holding Olema Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Olema Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Olema Pharmaceuticals' performance over market.| α | -0.78 | β | 2.59 |
Olema Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Olema Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Olema Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Olema Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Olema Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Olema Pharmaceuticals shares will generate the highest return on investment. By understating and applying Olema Pharmaceuticals stock market price indicators, traders can identify Olema Pharmaceuticals position entry and exit signals to maximize returns.
Olema Pharmaceuticals Return and Market Media
The median price of Olema Pharmaceuticals for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 5.66 with a coefficient of variation of 23.17. The daily time series for the period is distributed with a sample standard deviation of 1.33, arithmetic mean of 5.76, and mean deviation of 0.89. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 700761 shares by Graham G. Walmsley of Olema Pharmaceuticals at 6.75 subject to Rule 16b-3 | 12/13/2024 |
2 | Disposition of 14000 shares by Zojwalla Naseem of Olema Pharmaceuticals at 4.87 subject to Rule 16b-3 | 12/16/2024 |
3 | Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 | 01/03/2025 |
4 | Insider Trading | 01/08/2025 |
5 | Form 424B5 Olema Pharmaceuticals, - StreetInsider.com | 01/15/2025 |
6 | Olema Oncology to Present at the TD Cowen 45th Annual Health Care Conference | 02/19/2025 |
7 | Acquisition by Bohen Sean of 650000 shares of Olema Pharmaceuticals at 4.37 subject to Rule 16b-3 | 02/28/2025 |
8 | Olema Pharmaceuticals Earns Buy Rating from HC Wainwright - MarketBeat | 03/06/2025 |
About Olema Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Olema or other stocks. Alpha measures the amount that position in Olema Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Current Ratio | 12.62 | 12.33 | 14.18 | 27.06 | Net Debt To EBITDA | 0.2 | 0.63 | 0.73 | 0.69 |
Olema Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Olema Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Olema Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Olema Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Olema Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Olema Pharmaceuticals' management manipulating its earnings.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Olema Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Olema Pharmaceuticals Backtesting, Olema Pharmaceuticals Valuation, Olema Pharmaceuticals Correlation, Olema Pharmaceuticals Hype Analysis, Olema Pharmaceuticals Volatility, Olema Pharmaceuticals History and analyze Olema Pharmaceuticals Performance. For information on how to trade Olema Stock refer to our How to Trade Olema Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Olema Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.